{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:08:33Z","timestamp":1787069313912,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jchromb.2025.124872","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:47:36Z","timestamp":1764175656000},"page":"124872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["An optimized LC-ESI-MS\/MS assay for erythrocyte 6-TG and 6-MMPD: Addressing critical methodological considerations for thiopurine metabolite monitoring"],"prefix":"10.1016","volume":"1269","author":[{"given":"Ya-Min","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan-Sheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2025.124872_bb0005","first-page":"47","article-title":"Maintenance treatment in acute lymphoblastic leukemia: a clinical primer, Indian","volume":"91","author":"Krishnan","year":"2024","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jchromb.2025.124872_bb0010","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jchromb.2025.124872_bb0015","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/014107689208501213","article-title":"Pancytopenia related to azathioprine \u2014 an enzyme deficiency caused by a common genetic polymorphism: a review","volume":"85","author":"Anstey","year":"1992","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.jchromb.2025.124872_bb0020","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/bjc.1990.172","article-title":"Prognostic significance of hepatotoxicity during maintenance chemotherapy for childhood acute lymphoblastic leukaemia","volume":"61","author":"Schmiegelow","year":"1990","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jchromb.2025.124872_bb0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/08880019109028803","article-title":"Prognostic significance of methotrexate and 6-Mercaptopurine dosage during maintenance chemotherapy for childhood acute lymphoblastic leukemia","volume":"8","author":"Schmiegelow","year":"1991","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.jchromb.2025.124872_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.941182","article-title":"Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: a promising \u201cMINT\u201d sequencing strategy and therapeutic \u201cDNA-TG\u201d monitoring","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jchromb.2025.124872_bb0035","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0006-2952(75)90124-0","article-title":"Incorporation of the purine moieties of guanosine and inosine analogs into nucleotide pools of human erythrocytes","volume":"24","author":"Kong","year":"1975","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jchromb.2025.124872_bb0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2125.1993.tb00365.x","article-title":"Red blood cell hypoxanthine phosphoribosyltransferase activity measured using 6-mercaptopurine as a substrate: a population study in children with acute lymphoblastic leukaemia","volume":"36","author":"Lennard","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2025.124872_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00684949","article-title":"Plasma concentrations and organ distribution of thiopurines after oral application of azathioprine in mice","volume":"28","author":"Kurowski","year":"1991","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jchromb.2025.124872_bb0050","first-page":"1202","article-title":"Basic biochemical effects and mechanism of action of 6-Thioguanine","volume":"23","author":"Lepage","year":"1963","journal-title":"Cancer Res."},{"key":"10.1016\/j.jchromb.2025.124872_bb0055","first-page":"1627","article-title":"Pharmacology of 6-thioguanine in man","volume":"31","author":"LePage","year":"1971","journal-title":"Cancer Res."},{"key":"10.1016\/j.jchromb.2025.124872_bb0060","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1074\/jbc.M204243200","article-title":"Structure and dynamics of thioguanine-modified duplex DNA","volume":"278","author":"Somerville","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jchromb.2025.124872_bb0065","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jchromb.2025.124872_bb0070","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/0006-2952(93)90045-X","article-title":"6-mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts","volume":"45","author":"B\u00f6kkerink","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jchromb.2025.124872_bb0075","first-page":"2034","article-title":"Biochemical mechanisms for the synergism between 6-thioguanine and 6-(methylmercapto)purine ribonucleoside in sarcoma 180 cells","volume":"32","author":"Nelson","year":"1972","journal-title":"Cancer Res."},{"key":"10.1016\/j.jchromb.2025.124872_bb0080","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/gut.48.5.642","article-title":"Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease","volume":"48","author":"Cuffari","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jchromb.2025.124872_bb0085","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/gut.2003.032896","article-title":"Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease","volume":"53","author":"Wright","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jchromb.2025.124872_bb0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0928-0987(99)00027-5","article-title":"Metabolites of mercaptopurine in red blood cells: a relationship between 6-thioguanine nucleotides and 6-methylmercaptopurine metabolite concentrations in children with lymphoblastic leukemia","volume":"8","author":"Chrzanowska","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2025.124872_bb0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/clpt.1986.178","article-title":"Oral 6-mercaptopurine in childhood leukemia: parent drug pharmacokinetics and active metabolite concentrations","volume":"40","author":"Lennard","year":"1986","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2025.124872_bb0100","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF02897232","article-title":"6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and its relation to leukopenia","volume":"26","author":"Schmiegelowl","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jchromb.2025.124872_bb0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1096-911X(199602)26:2<85::AID-MPO3>3.0.CO;2-Q","article-title":"Hepatotoxicity of 6-mercaptopurine in childhood acute lymphocytic leukemia: pharmacokinetic characteristics","volume":"26","author":"Berkovitch","year":"1996","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.jchromb.2025.124872_bb0110","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jchromb.2025.124872_bb0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.clpt.2003.12.001","article-title":"Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity","volume":"75","author":"Nygaard","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2019","key":"10.1016\/j.jchromb.2025.124872_bb0120","first-page":"1095","article-title":"Clinical pharmacogenetics implementation consortium guideline for Thiopurine dosing based on TPMT and NUDT 15 genotypes: 2018 update","volume":"105","author":"Relling","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2025.124872_bb0125","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/cpt.3685","article-title":"Implementing pre-emptive pharmacogenetics: impact of early pharmacogenetic screening in a pediatric oncology cohort of 1,151 subjects","volume":"118","author":"Bernsen","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2025.124872_bb0130","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1021\/ac2031699","article-title":"Simultaneous quantification of eleven Thiopurine nucleotides by liquid chromatography-tandem mass spectrometry","volume":"84","author":"Hofmann","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2025.124872_bb0135","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3390\/molecules23071744","article-title":"Analytical and sample preparation protocol for therapeutic drug monitoring of 12 thiopurine metabolites related to clinical treatment of inflammatory bowel disease","volume":"23","author":"Pecher","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2025.124872_bb0140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.aca.2020.08.064","article-title":"Porous graphitic carbon based chromatography hyphenated with mass spectrometry: a new strategy for profiling thiopurine nucleotides in patients with inflammatory bowel diseases","volume":"1137","author":"Pecher","year":"2020","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2025.124872_bb0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-4347(00)86043-0","article-title":"Assay of an active metabolite of 6-thioguanine, 6-thioguanosine 5\u2032-monophosphate, in human red blood cells","volume":"229","author":"Dooley","year":"1982","journal-title":"J. Chromatogr. B. Biomed. Sci. App."},{"key":"10.1016\/j.jchromb.2025.124872_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/abio.1995.1046","article-title":"Determination of intracellular levels of 6-mercaptopurine metabolites in erythrocytes utilizing capillary electrophoresis with laser-induced fluorescence detection","volume":"224","author":"Rabel","year":"1995","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jchromb.2025.124872_bb0155","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jpba.2012.11.027","article-title":"Monitoring of thiopurine metabolites \u2013 a high-performance liquid chromatography method for clinical use","volume":"75","author":"Vikingsson","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124872_bb0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.2042-7158.1983.tb04255.x","article-title":"Assay of 6-thioguanine nucleotide, a major metabolite of azathioprine, 6-mercaptopurine and 6-thioguanine, in human red blood cells","volume":"35","author":"Lennard","year":"1983","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jchromb.2025.124872_bb0165","doi-asserted-by":"crossref","unstructured":"I. Bruunshuus, K. Schmiegelow, Analysis of 6-mercaptopurine, 6-thioguanine nucleotides, and 6-thiourie acid in biological fluids by high-performance liquid chromatography: technical note, Scand. J. Clin. Lab. Invest. 49 (1989) 779\u2013784. doi:https:\/\/doi.org\/10.3109\/00365518909091557.","DOI":"10.3109\/00365518909091557"},{"key":"10.1016\/j.jchromb.2025.124872_bb0170","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0003-2697(85)90148-4","article-title":"A rapid and sensitive high-performance liquid chromatographic assay for 6-mercaptopurine metabolites in red blood cells","volume":"144","author":"Lavi","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jchromb.2025.124872_bb0175","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0378-4347(87)80340-7","article-title":"Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells","volume":"423","author":"Lennard","year":"1987","journal-title":"J. Chromatogr. B. Biomed. Sci. App."},{"key":"10.1016\/j.jchromb.2025.124872_bb0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-4347(92)80347-S","article-title":"High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample","volume":"583","author":"Lennard","year":"1992","journal-title":"J. Chromatogr. B. Biomed. Sci. App."},{"key":"10.1016\/j.jchromb.2025.124872_bb0185","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinchem\/44.3.551","article-title":"Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC","volume":"44","author":"Dervieux","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2025.124872_bb0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jchromb.2003.08.006","article-title":"High-performance liquid chromatographic assay of metabolites of thioguanine and mercaptopurine in capillary blood","volume":"796","author":"Erb","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2025.124872_bb0195","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1373\/clinchem.2005.050831","article-title":"Liquid chromatography\u2013tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine\/6-mercaptopurine therapy","volume":"51","author":"Dervieux","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2025.124872_bb0200","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jchromb.2010.03.004","article-title":"Limited stability of thiopurine metabolites in blood samples: relevant in research and clinical practise","volume":"878","author":"De Graaf","year":"2010","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2025.124872_bb0205","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/039463201202500213","article-title":"A validated HPLC method for the monitoring of Thiopurine metabolites in whole blood in Paediatric patients with inflammatory bowel disease","volume":"25","author":"Cangemi","year":"2012","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.jchromb.2025.124872_bb0210","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/FTD.0b013e318283ed5d","article-title":"Improved method for therapeutic drug monitoring of 6-Thioguanine nucleotides and 6-Methylmercaptopurine in whole-blood by LC\/MSMS using isotope-labeled internal standards","volume":"35","author":"Kirchherr","year":"2013","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2025.124872_bb0215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/FTD.0000000000000362","article-title":"LC-MS\/MS analysis of erythrocyte Thiopurine nucleotides and their association with genetic variants in patients with Neuromyelitis Optica Spectrum disorders taking azathioprine","volume":"39","author":"Mei","year":"2017","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2025.124872_bb0220","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3343\/alm.2018.38.3.255","article-title":"Evaluation of stability of Thiopurine metabolites using a validated LC-MS\/MS method","volume":"38","author":"Yoo","year":"2018","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.jchromb.2025.124872_bb0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/FTD.0000000000000575","article-title":"Quantification of Thiopurine nucleotides in erythrocytes and clinical application to pediatric acute lymphoblastic leukemia","volume":"41","author":"Moon","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2025.124872_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2019.121802","article-title":"Highly sensitive and rapid determination of azathioprine metabolites in whole blood lysate by liquid chromatography\u2013tandem mass spectrometry","volume":"1136","author":"Miao","year":"2020","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2025.124872_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911885","article-title":"Improved HPLC quantification of 6-mercaptopurine metabolites in red blood cells: monitoring data and literature analysis","volume":"23","author":"Adam De Beaumais","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jchromb.2025.124872_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.836812","article-title":"LC\u2013MS\/MS method for measurement of Thiopurine nucleotides (TN) in erythrocytes and association of TN concentrations with TPMT enzyme activity","volume":"13","author":"Bajaj","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jchromb.2025.124872_bb0245","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3390\/metabo12121173","article-title":"A validated HPLC\u2013diode Array detection method for therapeutic drug monitoring of Thiopurines in pediatric patients: from bench to bedside","volume":"12","author":"Franzin","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.jchromb.2025.124872_bb0250","doi-asserted-by":"crossref","first-page":"14172","DOI":"10.1038\/s41598-023-41426-5","article-title":"Development of innovative methodology for determination of 6-thioguanine in whole blood erythrocytes by HPLC\u2013PDA-based technique for medical diagnostics purposes","volume":"13","author":"Noga","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2025.124872_bb0255","article-title":"Development and validation of a novel HPLC-UV method for simultaneous determination of azathioprine metabolites in human red blood cells","volume":"9","author":"Yu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jchromb.2025.124872_bb0260","series-title":"Clin. Appl. Mass Spectrom. Drug Anal","first-page":"443","article-title":"Quantification of thiopurine metabolites in human erythrocytes by liquid chromatography-tandem mass spectrometry (LC-MS\/MS)","author":"Li","year":"2024"},{"key":"10.1016\/j.jchromb.2025.124872_bb0265","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1021\/bi00892a002","article-title":"Dithiothreitol, a new protective reagent for SH groups","volume":"3","author":"Cleland","year":"1964","journal-title":"Biochemistry"},{"key":"10.1016\/j.jchromb.2025.124872_bb0270","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/clinchem\/44.12.2511","article-title":"Identification of 6-methylmercaptopurine derivative formed during acid hydrolysis of thiopurine nucleotides in erythrocytes, using liquid chromatography\u2013mass spectrometry, infrared spectroscopy, and nuclear magnetic resonance assay","volume":"44","author":"Dervieux","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2025.124872_bb0275","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/bcp.14258","article-title":"Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemia","volume":"86","author":"Zhou","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2025.124872_bb0280","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00007691-199710000-00003","article-title":"Patterns of azathioprine metabolites in neutrophils, lymphocytes, reticulocytes, and erythrocytes: relevance to toxicity and monitoring in recipients of renal allografts","volume":"19","author":"Bergan","year":"1997","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2025.124872_bb0285","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2125.2010.03867.x","article-title":"Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy","volume":"71","author":"Adam De Beaumais","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2025.124872_bb0290","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0140-6736(94)92400-7","article-title":"Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia","volume":"343","author":"Lilleyman","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jchromb.2025.124872_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-4347(00)00513-2","article-title":"Improved methods for determining the concentration of 6-thioguanine nucleotides and 6-methylmercaptopurine nucleotides in blood","volume":"757","author":"Pike","year":"2001","journal-title":"J. Chromatogr. B. Biomed. Sci. App."},{"key":"10.1016\/j.jchromb.2025.124872_bb0300","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1470-2045(17)30154-7","article-title":"DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial","volume":"18","author":"Nielsen","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jchromb.2025.124872_bb0305","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/cpt.2730","article-title":"DNA-Thioguanine nucleotides as a marker for Thiopurine induced late leukopenia after dose optimizing by NUDT15 C415T in Chinese patients with IBD","volume":"112","author":"Zhu","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2025.124872_bb0310","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s40262-024-01393-0","article-title":"Innovating Thiopurine therapeutic drug monitoring: a systematic review and Meta-analysis on DNA-Thioguanine nucleotides (DNA-TG) as an inclusive biomarker in Thiopurine therapy","volume":"63","author":"Bayoumy","year":"2024","journal-title":"Clin. Pharmacokinet."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322500426X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322500426X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:14:29Z","timestamp":1782497669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157002322500426X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":62,"alternative-id":["S157002322500426X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124872","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An optimized LC-ESI-MS\/MS assay for erythrocyte 6-TG and 6-MMPD: Addressing critical methodological considerations for thiopurine metabolite monitoring","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124872"}}